Inventor

WICKE KARSTEN

DE30 patents

⚠️ This page may combine multiple inventors who share the name “WICKE KARSTEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

WICKE KARSTEN

BASF AG

Substitute pyrimidine compounds and the use thereof

Substituted aza and diazacycloheptane and cyclooctane compounds and their use

3-substituted 3,4-dihydro-thieno[2,3-D]pyrimidine derivatives and production and use of the same

Use of thiazole and thiadiazole compounds

3-substituted pyrido[4′,3′:4,5]thieno[2,3-d]pyrimidine derivatives, their preparation and their use

Substituted AZA- and diazacycloheptane and -cyclooctane

Triazole compounds and the use thereof

3-substituted pyrido [3&#39;,4&#39;:4,5] Thieno [2,3-d] pyrimidine derivatives, and production and use of the same

ABBOTT LAB

3-substituted 3,4,5,7-tetrahedropyrrolo[3′,4′:4,5]thieno-[2,3-d]pyrimidine derivatives, their preparation and use

Triazole compounds and the use thereof as dopamine-D3 -ligands

3-Substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use

Substituted pyrimidine compounds and the use thereof

Triazole compounds and the use thereof

2-substituted 1,2-benzisothiazole derivatives and their use as serotonin antagonists (5-HT1A, 5HT1B and 5-HT1D)

HAUPT ANDREAS

N-phenyl- (piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HT6 receptor

N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HT6 receptor

Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

ABBOTT GMBH & CO KG

3-Substituted 3,4-dihydro-thieno[2,3-d]pyrimidin-4-one derivatives, production and use thereof

N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

ABBVIE DEUTSCHLAND

Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor

Quinoline compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HT6 receptor

Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor

Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor

TURNER SEAN COLM

Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-HT6 receptor

Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-HT6 receptor

SCHULTZ THOMAS

Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

3-substituted pyrido [3',4':4,5] Thieno [2,3-d] pyrimidine derivatives, and production and use of the same